Abstract: A stable and/or synergistic pharmaceutical composition including: a) predinisolone metasulfobenzoate (PMSB) or its acceptable salts, preferably prednisolone metasulfobenzoate sodium and b) 5-ASA, derivatives or pharmaceutically acceptable salts thereof, which is suitable for rectal administration.
Type:
Grant
Filed:
August 25, 2010
Date of Patent:
December 6, 2016
Assignees:
NORDIC PHARMA, DISPHAR INTERNATIONAL BV
Inventors:
Hans Schram, Michael Ikechukwu Ugwoke, Laura Buttafoco
Abstract: A stable and/or synergistic pharmaceutical composition including: a) predinisolone metasulfobenzoate (PMSB) or its acceptable salts, preferably prednisolone metasulfobenzoate sodium and b) 5-ASA, derivatives or pharmaceutically acceptable salts thereof, which is suitable for rectal administration.
Type:
Application
Filed:
August 25, 2010
Publication date:
June 14, 2012
Applicants:
DISPHAR INTERNATIONAL BV, NORDIC PHARMA
Inventors:
Hans Schram, Michael Ikechukwu Ugwoke, Laura Buttafoco